Skip to main navigation
Skip to search
Skip to main content
Bar-Ilan University Home
Help & FAQ
Link opens in a new tab
Search content at Bar-Ilan University
Home
Researchers
Organisations
Research output
Prizes
Student theses
Courses
Activities
Projects
Press/Media
Datasets
Equipment
Lipid Nanoparticle-based mRNA Therapeutics for Infectious Diseases
Raj Kumar
, Nagavendra Kommineni
, Keshaw Ram Aadil
, Nimeet Desai
, Naveen Bunekar
, Sagar Salave
, Raviteja Bulusu
, Deepak Kumar
, Lalitkumar K. Vora
University of Petroleum and Energy Studies
Thermo Fisher Scientific, Inc.
Govt. Digvijay Autonomous Post Graduate College
University of Liverpool
Chung Yuan Christian University
National Institute of Pharmaceutical Education and Research, Ahmedabad
University of Kansas
Florida A&M University
Manipal University Jaipur
Queen's University Belfast
Research output
:
Contribution to journal
›
Review article
›
peer-review
11
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Lipid Nanoparticle-based mRNA Therapeutics for Infectious Diseases'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Infectious Diseases
100%
Lipid Nanoparticles
100%
RNA Therapeutics
100%
Long Non-coding RNA (LncRNA)
100%
Adverse Effects
25%
COVID-19
25%
Controlled Release
25%
Biocompatibility
25%
Personalized Treatment
25%
Therapeutic Targeting
25%
Swift
25%
Translational Challenges
25%
Specific Targeting
25%
Herpes Simplex Virus
25%
Vaccine Development
25%
Clinical Development
25%
Respiratory Syncytial Virus
25%
MRNA-seq
25%
Rabies Virus
25%
Zika Virus
25%
MRNA Vaccine
25%
Intracellular Delivery
25%
Lipid Nanoparticle Formulations
25%
Safety Efficacy
25%
Rapidly Evolving
25%
Targeted Release
25%
Therapeutic Research
25%
Global Health Challenges
25%
Transformative Potential
25%
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
25%
Immune System Interaction
25%
Immunology and Microbiology
Lipid Nanoparticles
100%
COVID-19
33%
Severe Acute Respiratory Syndrome Coronavirus 2
33%
Human Respiratory Syncytial Virus
33%
Infectious Agent
33%
Herpes Simplex Virus
33%
Global Health
33%
Zika Virus
33%
Immune System
33%
mRNA Stability
33%
Therapeutic Research
33%
Rabies virus
33%
Pharmacology, Toxicology and Pharmaceutical Science
Solid Lipid Nanoparticle
100%
Messenger RNA
100%
Diseases
100%
Biocompatibility
14%
Infectious Agent
14%
Vaccine Development
14%
mRNA Vaccine
14%
Pandemic
14%
Adverse Event
14%
SARS Coronavirus
14%
Herpes Simplex Virus
14%
Zika Virus
14%
Human Respiratory Syncytial Virus
14%
Rabies virus
14%
Biochemistry, Genetics and Molecular Biology
Rabies virus
16%
Therapeutic Research
16%